| |
Lifeline BioTechnologies Added to Group of Biotechnology Leaders On Biospace.com
RENO, Nev., Oct. 27 /PRNewswire/ -- Lifeline BioTechnologies Inc. (OTC Bulletin Board: LBTI - news) and Biospace.com announced today the inclusion of Lifeline BioTechnologies to www.biospace.com. A brief company profile and description of Lifeline's leading edge technology are now available on the site.
BioSpace(R) is a high-traffic, business-to-business Internet ''hub'' site serving the global biopharmaceutical industry. The overriding goal of BioSpace(R) is to facilitate informed and timely decision-making by providing critical and organized bioscience information in one location on the World Wide Web. BioSpace(R) is an online, on-going industry-specific trade conference which presently attracts over 70,000 visitors monthly looking for the latest news, company information, industry events and career opportunities. These visitors download over 600,000 page views per month from the ''hub'' site -- with a consistent growth rate of 10 percent per month.
Lifeline BioTechnologies, Inc.'s (Lifeline) has developed a non-invasive test for early breast cancer detection. The test is incorporated into a proprietary product called First Warning(TM). In preliminary pilot studies, First Warning(TM) demonstrated great promise in detecting formation of extremely early stage breast lesions, particularly in younger women. Management believes the product is an alternative to other breast cancer detection products, including technology from Trex Medical Corporation and Computerized Thermal Imaging, Inc.
The second product division under Lifeline BioTechnologies is a line of nutritional food supplements packaged and sold under the tradename NATURE'S CREATIONS. These supplements are marketed and directed towards people afflicted with degenerative diseases that are commonly found in the aging population. These diseases include cancer (breast, colon and prostate) cardiovascular, osteoporosis and mental alertness.
For more information on Lifeline BioTechnologies, please visit www.lbti.com.
Financial Statements in this press release (if any) other than historical facts are ''forward-looking'' statements with the meaning of section 27A of the Securities Act of 1933, section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.
SOURCE: Lifeline BioTechnologies, Inc.
-------------------------------------------------------------------------------- |
|
